关注
Andrew Anighoro
Andrew Anighoro
未知所在单位机构
在 relationrx.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Polypharmacology: challenges and opportunities in drug discovery: miniperspective
A Anighoro, J Bajorath, G Rastelli
Journal of medicinal chemistry 57 (19), 7874-7887, 2014
10432014
Application of a post-docking procedure based on MM-PBSA and MM-GBSA on single and multiple protein conformations
M Sgobba, F Caporuscio, A Anighoro, C Portioli, G Rastelli
European Journal of Medicinal Chemistry 58, 431-440, 2012
932012
Role of bifidobacteria in the hydrolysis of chlorogenic acid
S Raimondi, A Anighoro, A Quartieri, A Amaretti, FA Tomás‐Barberán, ...
Microbiologyopen 4 (1), 41-52, 2015
732015
Three-dimensional similarity in molecular docking: prioritizing ligand poses on the basis of experimental binding modes
A Anighoro, J Bajorath
Journal of Chemical Information and Modeling 56 (3), 580-587, 2016
532016
Structure-based discovery of the first allosteric inhibitors of cyclin-dependent kinase 2
G Rastelli, A Anighoro, M Chripkova, L Carrassa, M Broggini
Cell Cycle 13 (14), 2296-2305, 2014
532014
Learning protein-ligand binding affinity with atomic environment vectors
R Meli, A Anighoro, MJ Bodkin, GM Morris, PC Biggin
Journal of Cheminformatics 13 (1), 59, 2021
512021
Computational polypharmacology analysis of the heat shock protein 90 interactome
A Anighoro, D Stumpfe, K Heikamp, K Beebe, LM Neckers, J Bajorath, ...
Journal of chemical information and modeling 55 (3), 676-686, 2015
302015
Enrichment factor analyses on G-protein coupled receptors with known crystal structure
A Anighoro, G Rastelli
Journal of chemical information and modeling 53 (4), 739-743, 2013
242013
Heat shock protein 90 and serine/threonine kinase B-Raf inhibitors have overlapping chemical space
A Anighoro, L Pinzi, G Marverti, J Bajorath, G Rastelli
RSC advances 7 (49), 31069-31074, 2017
222017
Predicting bioactive conformations and binding modes of macrocycles
A Anighoro, A de la Vega de León, J Bajorath
Journal of computer-aided molecular design 30, 841-849, 2016
212016
Insights into the interaction of negative allosteric modulators with the metabotropic glutamate receptor 5: discovery and computational modeling of a new series of ligands with …
A Anighoro, D Graziani, I Bettinelli, A Cilia, C De Toma, M Longhi, ...
Bioorganic & Medicinal Chemistry 23 (13), 3040-3058, 2015
192015
Underappreciated chemical interactions in protein–ligand complexes
A Anighoro
Quantum mechanics in drug discovery, 75-86, 2020
172020
Binding mode similarity measures for ranking of docking poses: a case study on the adenosine A2A receptor
A Anighoro, J Bajorath
Journal of computer-aided molecular design 30, 447-456, 2016
152016
A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease
JA Timmons, A Anighoro, RJ Brogan, J Stahl, C Wahlestedt, DG Farquhar, ...
Elife 11, e68832, 2022
112022
Recover: sequential model optimization platform for combination drug repurposing identifies novel synergistic compounds in vitro
P Bertin, J Rector-Brooks, D Sharma, T Gaudelet, A Anighoro, T Gross, ...
arXiv preprint arXiv:2202.04202, 2022
82022
Deep learning in structure-based drug design
A Anighoro
Artificial Intelligence in Drug Design, 261-271, 2022
82022
Compound ranking based on fuzzy three-dimensional similarity improves the performance of docking into homology models of g-protein-coupled receptors
A Anighoro, J Bajorath
ACS omega 2 (6), 2583-2592, 2017
82017
BEAR, a molecular docking refinement and rescoring method
A Anighoro, G Rastelli
Computational Molecular Bioscience 3 (2), 27-31, 2013
72013
A hybrid virtual screening protocol based on binding mode similarity
A Anighoro, J Bajorath
Rational Drug Design: Methods and Protocols, 165-175, 2018
62018
RECOVER identifies synergistic drug combinations in vitro through sequential model optimization
P Bertin, J Rector-Brooks, D Sharma, T Gaudelet, A Anighoro, T Gross, ...
Cell Reports Methods 3 (10), 2023
52023
系统目前无法执行此操作,请稍后再试。
文章 1–20